Nutritional Assessment in Patients after Gastric Electrical Stimulation (GES)

Basit Öğe Kaydı
dc.contributor.authorKochar, Tanureet
dc.contributor.authorCai, Wenjing
dc.contributor.authorGuardiola, John J.
dc.contributor.authorMathur, Prateek
dc.contributor.authorHassan, Hamza
dc.contributor.authorAtassi, Hadi
dc.contributor.authorStocker, Abigail
dc.date.accessioned2024-02-23T14:21:13Z
dc.date.available2024-02-23T14:21:13Z
dc.date.issued2024
dc.departmentNEÜen_US
dc.description.abstractBackground: Gastric electrical stimulation (GES) is used for patients with drug-refractory gastroparesis (Gp) symptoms. Approximately two-thirds of patients with Gp symptoms are either overweight or obese. We aimed to assess symptoms and nutritional status pre-GES and post-GES placement in a large sample of drug-refractory Gp patients.Methods: We conducted a chart review of 282 patients with drug-refractory Gp who received temporary followed by permanent GES at an academic medical center. Gastrointestinal symptoms were collected by a traditional standardized PRO (0-4, 0 being asymptomatic and 4 being worst symptoms), baseline nutritional status by BMI plus subjective global assessment (SGA score A, B, C, for mild, moderate, and severe nutritional deficits), ability to tolerate diet, enteral tube access, and parenteral therapy were assessed at baseline and after permanent GES placement.Results: Comparing baseline with permanent, GES was found to significantly improve upper GI symptoms in all quartiles. Of the 282 patients with baseline body mass index (BMI) information, 112 (40%) patients were severely malnourished at baseline, of which 36 (32%) patients' nutritional status improved after GES. Among all patients, 76 (68%) patients' nutritional status remained unchanged. Many patients with high BMI were malnourished by SGA.Conclusion: We conclude that symptomatic patients of different BMIs showed improvement in their GI symptoms irrespective of baseline nutritional status. Severely malnourished patients were found to have an improvement in their nutritional status after GES therapy. We conclude that BMI, even if high, is not by itself a contraindication for GES therapy for symptomatic patients.en_US
dc.description.sponsorshipGI Motility Clinicen_US
dc.description.sponsorshipThe authors would like to thank the colleagues and staff at the University of Louisville Health Jewish Hospital and the GI Motility Clinic for their help. They also thank Catherine McBride for their help with manuscript preparation.en_US
dc.identifier.doi10.1097/MCG.0000000000001826
dc.identifier.endpage142en_US
dc.identifier.issn0192-0790
dc.identifier.issn1539-2031
dc.identifier.issue2en_US
dc.identifier.pmid36626193en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage136en_US
dc.identifier.urihttps://doi.org/10.1097/MCG.0000000000001826
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13500
dc.identifier.volume58en_US
dc.identifier.wosWOS:001154705000014en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofJournal Of Clinical Gastroenterologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGastroparesisen_US
dc.subjectNauseaen_US
dc.subjectVomitingen_US
dc.subjectMalnutritionen_US
dc.subjectGastric Electrical Stimulationen_US
dc.titleNutritional Assessment in Patients after Gastric Electrical Stimulation (GES)en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu